Differences in speech and language abilities between children with 22q11.2 deletion syndrome and children with phenotypic features of 22q11.2 deletion syndrome but without microdeletion

被引:19
|
作者
Rakonjac, Marijana [1 ,2 ]
Cuturilo, Goran [3 ,4 ]
Stevanovic, Milena [5 ]
Jelicic, Ljiljana [1 ,2 ]
Subotic, Misko [1 ,2 ]
Jovanovic, Ida [3 ,4 ]
Drakulic, Danijela [5 ]
机构
[1] Inst Expt Phonet & Speech Pathol, Jovanova 35, Belgrade, Serbia
[2] Life Act Adv Ctr, Jovanova 35, Belgrade, Serbia
[3] Univ Belgrade, Fac Med, Dr Subotica 8, Belgrade 11000, Serbia
[4] Univ Childrens Hosp, Tirsova 10, Belgrade 11000, Serbia
[5] Univ Belgrade, Inst Mol Genet & Genet Engn, Vojvode Stepe 444a, Belgrade 11010, Serbia
关键词
22q11.2DS; Speech and language delay; 5-10 year old children; Congenital heart malformations; CONGENITAL HEART-DISEASE; DE-NOVO MUTATIONS; VELOCARDIOFACIAL SYNDROME; BRAIN-DEVELOPMENT; GENE-EXPRESSION; TRANSPOSITION; IMPAIRMENT; ARTERIES; OUTCOMES; FETUSES;
D O I
10.1016/j.ridd.2016.05.006
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with speech and language delay (SLD). Approximately 75% of children with 22q11.2 microdeletion have congenital heart malformations (CHM) which after infant open-heart surgery might lead to SLD. Aims: The purpose of this study was to determine whether factors associated with microdeletion contribute to SLD in children with 22q11.2DS. Methods and procedures: We compared speech and language abilities of two groups of school-aged children: those with 22q11.2 microdeletion (E1) and those with the phenotype resembling 22q11.2DS but without the microdeletion (E2). An age-matched group of typically developing children was also tested. Outcomes and results: The obtained results revealed that children from group E1 have lower level of speech and language abilities compared to children from group E2 and control group. Additionally, mild to moderate SLD was detected in children from group E2 compared to children from the control group. Conclusions and implications: The obtained results imply that both CHM after infant open-heart surgery and other factors associated with 22q11.2 microdeletion, contribute to SLD in patients with 22q11.2 microdeletion. Based on this, we could postulate that there is/are some potential candidate gene(s), located in the 22q11.2 region, whose function could be important for speech and language development. (c) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 50 条
  • [41] Otolaryngologic manifestations of the 22q11.2 deletion syndrome
    Dyce, O
    McDonald-McGinn, D
    Kirschner, RE
    Zackai, E
    Young, K
    Jacobs, IN
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (12) : 1408 - 1412
  • [42] 22q11.2 deletion syndrome: an anaesthetic perspective
    Kemp, N.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2021, 27 (05) : 206 - 210
  • [43] Labyrinthine malformation in the 22q11.2 deletion syndrome
    Hopsu, Erkki
    Markkola, Antti
    Pitkaranta, Anne
    CLINICAL DYSMORPHOLOGY, 2007, 16 (01) : 67 - 68
  • [44] Developmental trajectories in 22q11.2 deletion syndrome
    Swillen, Ann
    McDonald-McGinn, Donna
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2015, 169 (02) : 172 - 181
  • [45] Olfactory deficits in deletion syndrome 22q11.2
    Romanos, Marcel
    Schecklmann, Martin
    Kraus, Katharina
    Fallgatter, Andreas J.
    Warnke, Andreas
    Lesch, Klaus-Peter
    Gerlach, Manfred
    SCHIZOPHRENIA RESEARCH, 2011, 129 (2-3) : 220 - 221
  • [46] 22q11.2 deletion syndrome in diverse populations
    Kruszka, Paul
    Addissie, Yonit A.
    McGinn, Daniel E.
    Porras, Antonio R.
    Biggs, Elijah
    Share, Matthew
    Crowley, T. Blaine
    Chung, Brian H. Y.
    Mok, Gary T. K.
    Mak, Christopher C. Y.
    Muthukumarasamy, Premala
    Thong, Meow-Keong
    Sirisena, Nirmala D.
    Dissanayake, Vajira H. W.
    Paththinige, C. Sampath
    Prabodha, L. B. Lahiru
    Mishra, Rupesh
    Shotelersuk, Vorasuk
    Ekure, Ekanem Nsikak
    Sokunbi, Ogochukwu Jidechukwu
    Kalu, Nnenna
    Ferreira, Carlos R.
    Duncan, Jordann-Mishael
    Patil, Siddaramappa Jagdish
    Jones, Kelly L.
    Kaplan, Julie D.
    Abdul-Rahman, Omar A.
    Uwineza, Annette
    Mutesa, Leon
    Moresco, Angelica
    Gabriela Obregon, Maria
    Richieri-Costa, Antonio
    Gil-da-Silva-Lopes, Vera L.
    Adeyemo, Adebowale A.
    Summar, Marshall
    Zackai, Elaine H.
    McDonald-McGinn, Donna M.
    Linguraru, Marius George
    Muenke, Maximilian
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (04) : 879 - 888
  • [47] Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome
    McLean-Tooke, A.
    Spickett, G. P.
    Gennery, A. R.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (01) : 1 - 7
  • [48] Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome
    Lima, Kari
    Abrahamsen, Tore G.
    Wolff, Anette Boe
    Husebye, Eystein
    Alimohammadi, Mohammad
    Kampe, Olle
    Folling, Ivar
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (02) : 345 - 352
  • [49] Opitz GBBB syndrome and the 22q11.2 deletion
    Lacassie, Y
    Arriaza, MI
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 62 (03): : 318 - 318
  • [50] NEUROCOGNITIVE FUNCTIONING IN 22Q11.2 DELETION SYNDROME
    Gur, Raquel E.
    Emanuel, Beverly S.
    Yi, James J.
    McDonald-McGinn, Donna M.
    Tang, Sunny X.
    Zackai, Elaine H. J.
    Whinna, Daneen
    Souders, Margaret C.
    Calkins, Monica E.
    Kohler, Christian G.
    Savitt, Adam
    Gur, Ruben C.
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S76 - S76